Albertsons Companies, Inc. and Rite Aid Corporation to Host Analyst Presentation
Albertsons Companies, Inc. one of the nation’s largest grocery retailers, and Rite Aid Corporation (NYSE:RAD), one of the
nation's leading drugstore chains, announced today that they will host a joint analyst event on May 15, 2018. The
management teams of both companies will discuss the strategic and financial benefits of the proposed merger transaction between
Albertsons Cos. and Rite Aid.
As previously announced on February 20, 2018, Albertsons Cos. and Rite Aid announced a definitive merger agreement under which
privately held Albertsons Cos. will merge with publicly traded Rite Aid.
In-person attendance is by invitation only; however, the event will be webcast live beginning at 9 a.m. until approximately
2 p.m. ET. The webcast can be accessed in the Investor Relations sections of www.albertsonscompanies.com and www.riteaid.com, along with an accompanying presentation and will be available for replay until the Rite Aid
special stockholders meeting.
About Albertsons Companies
Albertsons Companies, Inc. is one of the largest food and drug retailers in the United States, with both a strong local presence
and national scale. Albertsons Cos. operates stores across 35 states and the District of Columbia under 20 well-known banners
including Albertsons, Safeway, Vons, Jewel-Osco, Shaw’s, Acme, Tom Thumb, Randalls, United Supermarkets, Pavilions, Star Market,
Haggen and Carrs, as well as meal kit company Plated based in New York City. Albertsons Cos. is committed to helping people across
the country live better lives by making a meaningful difference, neighborhood by neighborhood. In 2016 alone, along with the
Albertsons Companies Foundation, the company gave nearly $300 million in food and financial support. These efforts helped millions
of people in the areas of hunger relief, education, cancer research and treatment, programs for people with disabilities and
veterans outreach.
About Rite Aid Corporation
Rite Aid Corporation (NYSE: RAD) is one of the nation's leading drugstore chains with fiscal 2018 annual revenues of $21.5
billion. The company also owns EnvisionRxOptions, a multi-faceted healthcare and pharmacy benefit management (PBM) company
supporting a membership base of more than 22 million members; RediClinic, a convenient care clinic operator with locations in
Delaware, New Jersey, Pennsylvania, Texas and Washington; and Health Dialog, a leading provider of population health management
solutions including analytics, a multi-channel coaching platform and shared decision-making tools. Information about Rite Aid,
including corporate background and press releases, is available through the company's website at www.riteaid.com.
Important Notice Regarding Forward-Looking Statements
This communication contains certain “forward-looking statements” within the meaning of the Securities Act of 1933 and the
Securities Exchange Act of 1934, both as amended by the Private Securities Litigation Reform Act of 1995. Statements that are not
historical facts, including statements about the pending merger between Rite Aid Corporation (“Rite Aid”) and Albertsons Companies,
Inc. (“Albertsons”) and the transactions contemplated thereby, and the parties perspectives and expectations, are forward looking
statements. Such statements include, but are not limited to, statements regarding the benefits of the proposed merger, integration
plans, expected synergies and revenue opportunities, anticipated future financial and operating performance and results, including
estimates for growth and the expected timing of the transactions contemplated by the merger agreement. The words “expect,”
“believe,” “estimate,” “intend,” “plan” and similar expressions indicate forward-looking statements. These forward-looking
statements are not guarantees of future performance and are subject to various risks and uncertainties, assumptions (including
assumptions about general economic, market, industry and operational factors), known or unknown, which could cause the actual
results to vary materially from those indicated or anticipated. Such risks and uncertainties include, but are not limited to, risks
related to the expected timing and likelihood of completion of the pending merger, including the risk that the transaction may not
close due to one or more closing conditions to the transaction not being satisfied or waived, such as regulatory approvals not
being obtained, on a timely basis or otherwise, or that a governmental entity prohibited, delayed or refused to grant approval for
the consummation of the transaction or required certain conditions, limitations or restrictions in connection with such approvals,
or that the required approval of the merger agreement by the stockholders of Rite Aid was not obtained; risks related to the
ability of Albertsons and Rite Aid to successfully integrate the businesses; the occurrence of any event, change or other
circumstances that could give rise to the termination of the merger agreement (including circumstances requiring Rite Aid to pay
Albertsons a termination fee pursuant to the merger agreement); the risk that there may be a material adverse change of Rite Aid or
Albertsons; risks related to disruption of management time from ongoing business operations due to the proposed transaction; the
risk that any announcements relating to the proposed transaction could have adverse effects on the market price of Rite Aid’s
common stock, and the risk that the proposed transaction and its announcement could have an adverse effect on the ability of Rite
Aid to retain customers and retain and hire key personnel and maintain relationships with their suppliers and customers and on
their operating results and businesses generally; risks related to successfully integrating the businesses of the companies, which
may result in the combined company not operating as effectively and efficiently as expected; the risk that the combined company may
be unable to achieve cost-cutting synergies or it may take longer than expected to achieve those synergies; and risks associated
with the financing of the proposed transaction. A further list and description of risks and uncertainties can be found in Rite
Aid’s Annual Report on Form 10-K for the fiscal year ended March 3, 2018 filed with the Securities and Exchange Commission (“SEC”)
and in the registration statement on Form S-4, as it may be amended, that was filed with the SEC by Albertsons on April 6, 2018 in
connection with the proposed merger, and other documents that the parties may file or furnish with the SEC, which you are
encouraged to read. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove
incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. Accordingly,
you are cautioned not to place undue reliance on these forward-looking statements. Forward-looking statements relate only to the
date they were made, and Rite Aid undertakes no obligation to update forward-looking statements to reflect events or circumstances
after the date they were made except as required by law or applicable regulation.
Additional Information and Where to Find It
In connection with the proposed merger involving Rite Aid and Albertsons, Rite Aid and Albertsons have prepared and Albertsons
has filed with the SEC on April 6, 2018 a registration statement on Form S-4 that includes a proxy statement of Rite Aid that also
constitutes a prospectus of Albertsons. The registration statement is not yet final and will be amended. Rite Aid will mail the
proxy statement/prospectus and a proxy card to each stockholder entitled to vote at the special meeting relating to the proposed
merger. Rite Aid and Albertsons also plan to file other relevant documents with the SEC regarding the proposed merger. INVESTORS
ARE URGED TO READ THE DEFINITIVE PROXY STATEMENT/PROSPECTUS WHEN IT BECOMES AVAILABLE, AS WELL AS OTHER DOCUMENTS FILED WITH THE
SEC, BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. RITE AID’S EXISTING PUBLIC FILINGS WITH THE SEC SHOULD ALSO BE READ,
INCLUDING THE RISK FACTORS CONTAINED THEREIN.
Investors and security holders may obtain copies of the Form S-4, including the proxy statement/prospectus, as well as other
filings containing information about Rite Aid, free of charge, from the SEC’s website (www.sec.gov). Investors and security holders may also obtain Rite Aid’s SEC filings in connection with the
transaction, free of charge, from Rite Aid’s website (www.RiteAid.com) under the link “Investor Relations” and then under the tab “SEC Filings,” or by directing a
request to Rite Aid, Byron Purcell, Attention: Senior Director, Treasury Services & Investor Relations. Copies of documents
filed with the SEC by Albertsons will be made available, free of charge, on the SEC’s website (www.sec.gov) and on Albertsons’ website at www.albertsonscompanies.com.
Participants in Solicitation
Rite Aid, Albertsons and their respective directors, executive officers and employees and other persons may be deemed to be
participants in the solicitation of proxies from the holders of Rite Aid common stock in respect of the proposed transaction.
Information regarding Rite Aid’s directors and executive officers is available in its definitive proxy statement for Rite Aid’s
2017 annual meeting of stockholders filed with the SEC on June 7, 2017, as modified or supplemented by any Form 3 or Form 4 filed
with the SEC since the date of such definitive proxy statement. Information about the directors and executive officers of
Albertsons is set forth in the registration statement on Form S-4, including the proxy statement/prospectus, as it may be amended,
that has been filed with the SEC on April 6, 2018. Other information regarding the interests of the participants in the proxy
solicitation may be included in the definitive proxy statement/prospectus when it becomes available. These documents can be
obtained free of charge from the sources indicated above.
Non-Solicitation
This communication shall not constitute an offer to sell or the solicitation of an offer to sell or the solicitation of an offer
to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale
would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offer of securities
shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.
![](http://cts.businesswire.com/ct/CT?id=bwnews&sty=20180514005590r1&sid=mstr1&distro=nx&lang=en)
For Albertsons Companies
INVESTORS:
Melissa Plaisance, 925-226-5115
melissa.plaisance@albertsons.com
or
MEDIA:
Christine Wilcox, 208-395-4163
christine.wilcox@albertsons.com
or
For Rite Aid
INVESTORS:
Byron Purcell, 717-975-5809
investor@riteaid.com
or
MEDIA:
Ashley Flower, 717-975-5718
aflower@riteaid.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20180514005590/en/